From research to industry, Flagstaff fuels Arizona’s bioscience growth / Flagstaff Business News
Flagstaff is quickly becoming a standout in Arizona’s growing bioscience sector, with business leaders and educational institutions aligning their strategies with the state’s long-term vision outlined in Arizona’s Bioscience Roadmap.
$3M will allow University of Arizona researchers to develop scope to help endometriosis diagnosis / KJZZ
Endometriosis is a painful condition where the sensitive tissue that lines the inside of the uterus ends up growing elsewhere in the reproductive system. A $3 million grant to University of Arizona researchers could help improve diagnosis.
Scottsdale biotech firm advances Parkinson’s test development / Phoenix Business Journal
A new federal regulatory designation will allow Scottsdale biotech company CND Life Sciences to more quickly advance its medical diagnostic test for neurodegenerative conditions, including Parkinson’s disease.
Canadian medtech company NeuroCatch sets up US HQ in Phoenix / Phoenix Business Journal
NeuroCatch Inc., a brain health technology company based in British Columbia with more than a dozen employees, is moving its U.S. headquarters to the 850 PBC building within the Phoenix Bioscience Core, a 30-acre life sciences innovation district in downtown Phoenix.
Scottsdale-based Xcellerant innovative fund targets $100M, lowering barriers to venture capital investing / Phoenix Business Journal
Scottsdale-based Xcellerant Ventures has launched a new fund that makes it easier for working professionals to invest in startups by providing access to investments in early-stage, high-growth companies with flexible terms, lower investment minimums and no carried interest. Read more: Arizona startups raise $164 million in Q3, led by AI and logistics investments
10 Arizona startups to watch heading into 2026 / AZ Big Media
Solera Health, Datavant, and Reference Medicine are all named as startups to watch next year by AZ Big Media.
Venture Madness announces leadership change as longtime CEO departs, new director steps in / Phoenix Business Journal
Karen Katzorke is stepping down as president and CEO of Venture Madness by Invest Southwest after 20 years with the organization. Aaron Favreau will follow as the organization’s new executive director, effective Nov. 7.
Upcoming Events
Oct. 17: Voice of the Patient
Oct 28: AZBioPEERS: Getting the Word Out
Nov. 14: Celebrating Innovation Summit 2025
Check out our new Bio Blog for the latest news about Arizona’s Bioscience Roadmap.